NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Prompt Diagnostics

Prompt Diagnostics

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://prompt-dx.com/

Last Round

Grant

Oct 22, 2025

Total Funding Raised

$2.35M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Prompt Diagnostics is a biotechnology company that develops portable, rapid PCR-based diagnostic platforms for point-of-care infectious disease testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

point-of-care testingPOCTrapid PCRmolecular diagnosticsmicrofluidic cartridgesdiagnostic instrumentsample-to-answerlab-on-a-chipmagnetofluidicsassay designrapid testingclinical diagnosticsportable diagnosticsmedical device startupbiotech hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prompt Diagnostics Comparables

Compare Prompt Diagnostics with similar companies based on industry and business-model similarity.

Prompt Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Novel Microdevices
89%
QuantuMDx
83%
SD Biosensor Inc
76%

Prompt Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 22, 2025
GrantJun 27, 2024
AcceleratorMar 20, 2023
AcceleratorFeb 2, 2022
GrantSep 30, 2021

Prompt Diagnostics Investors

Notable investors and investment history

Prompt Diagnostics investors
InvestorRounds
CARB-XGrant
LifeBridge HealthAccelerator
NIH RADxGrant
Bill & Melinda Gates FoundationGrant
NucleateAccelerator
National Science FoundationAccelerator, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 34% MoM, from 1.3K to 1.8K.

  • Oct 22, 2025

    $1.25M grant awarded by the National Science Foundation.

Prompt Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prompt Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prompt Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range5
Year Founded2020
Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.